What's Happening?
Johnson & Johnson is actively recruiting for a Director, APSO, Patient & Customer Experience, to be based in various Asia Pacific (APAC) locations including Singapore, Mumbai, Hong Kong, Manila, Bangkok, Beijing, Ho Chi Minh, Sydney, Seoul, Taipei, Chiyoda,
and Kuala Lumpur. This role is central to the company's APAC Commercial Excellence strategy, focusing on leading the regional Patient Experience (PX) and Patient Support Program (PSP) strategy. The director will also be responsible for shaping commercial decision-making and integrating the sales channel into broader Customer Experience (CX) initiatives. Key responsibilities include defining and leading the APAC PX and PSP strategy to advance business priorities and patient outcomes, strengthening the APAC Patient Experience community, and partnering with Regional Brand Leads to embed patient experience into launch strategies. The position also involves serving as the regional PxP Business Product Owner, co-creating patient-centric solutions, and ensuring compliance across the region by establishing regional guidelines and SOPs for PSP programs and PX initiatives. The role requires a minimum of 10 years of experience in the pharmaceutical, healthcare, or related industry, with demonstrated leadership in regional or large-scale customer, patient, commercial, or digital initiatives.
Why It's Important?
This strategic hire by Johnson & Johnson underscores the growing importance of patient and customer experience in the pharmaceutical and healthcare industries, particularly within the dynamic APAC region. By focusing on a dedicated leadership role for PX and PSP, Johnson & Johnson aims to enhance patient outcomes and market impact, which can lead to increased brand loyalty and competitive advantage. The integration of the sales channel into broader CX initiatives signifies a shift towards a more holistic and patient-centric approach to commercial operations. This move is crucial for optimizing engagement with healthcare professionals and patients, ensuring that treatments are not only effective but also supported by comprehensive patient care programs. The emphasis on compliance and privacy in patient data management reflects the increasing regulatory scrutiny and ethical considerations in healthcare, making this role vital for maintaining trust and adherence to industry standards. Ultimately, this investment in patient and customer experience leadership is expected to drive business growth and strengthen Johnson & Johnson's position in the APAC healthcare market.
What's Next?
The successful candidate for the Director, APSO, Patient & Customer Experience role will be tasked with immediately defining and leading the APAC Patient Experience and Patient Support Program strategy. This will involve establishing regional guidelines and standard operating procedures for compliant PSP programs and PX initiatives, working closely with legal, privacy, and compliance departments. A key next step will be to lead the APAC Patient Experience community, fostering collaboration and sharing best practices across markets to elevate patient experience from operational tasks to a strategic driver of brand strategy and growth. The director will also need to partner with Regional Brand Leads to integrate patient experience into upcoming product launch strategies, ensuring a consistent APAC patient go-to-market approach. Furthermore, the role will involve preparing markets for future CONNEXT AI capabilities and ensuring that field behaviors and digital content adoption align with the goal of enhancing J&J Innovative Medicine's competitiveness in the region. The focus will be on implementing outcome measurement frameworks to demonstrate patient, customer, operational, and business value, while continuously ensuring compliance and patient safety.
Beyond the Headlines
The creation of this senior leadership role for Patient & Customer Experience at Johnson & Johnson reflects a broader industry trend towards hyper-personalization and patient-centric care models. Beyond the immediate business objectives, this role highlights the ethical imperative for pharmaceutical companies to not only develop innovative medicines but also to ensure that patients have comprehensive support throughout their treatment journey. The emphasis on integrating digital capabilities and AI into patient and customer engagement signifies a long-term shift in how healthcare companies interact with their stakeholders, moving towards more data-driven and technologically advanced approaches. This could lead to more equitable access to information and support for patients, potentially reducing healthcare disparities across the diverse APAC region. Furthermore, the focus on compliance and privacy in patient data management underscores the evolving legal and ethical landscape surrounding health data, setting a precedent for responsible innovation in patient support programs. This strategic investment could ultimately redefine the standard of care and patient engagement in the global pharmaceutical industry.
